Evidence map›Paper›PMID 39035187›Full record

ReviewFrontiers in public health2024

Promoting the development of ethnic medicine in China: policy evaluation and optimization countermeasures.

Yafei Lan, Junlin Zhang, Zufang Jiao, Ningying Mao

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yafei LanSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Junlin ZhangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Zufang JiaoSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Ningying MaoSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coordinated development of ethnic medicine is a basic necessity for steady construction of a healthy China. This process includes closely following domestic and foreign policies, including changes, through the optimization of policies; shaping the new direction of the development of national medicine; and achieving comprehensive technological and industrial upgrades. As such, ensuring the all-round development of national medicine in China remains a great challenge. Methods: This paper takes the relevant policies of national and local ethnic medicine issued by the government as the research object, and, through the full interpretation of the policy-issuing body, policy content, and policy effectiveness, deeply analyzes the current situation of the policy's role in ethnic medicine and explores the distribution of policy types, subject-cooperation modes, and scoring levels in various dimensions. Results: This study found that, in the new era of pharmaceutical reform, the State lacks a variety of special policies on ethnomedicine, and there is also an imbalance in the use of policy tools at both the central and local levels as well as synergies in the implementation of policies that need to be further strengthened. Discussion: There remains a need to continue to improve the policy-evaluation system, optimize the structure for the use of policy tools, and improve the rates of application and implementation of the national medicine policy by strengthening cross-provincial and multisectoral cooperation to promote the revitalization of the national medicine industry in China.

Indexed as

Health PolicyChinaHumansMedicine, Chinese TraditionalPolicy Makingcooperation subjectsethnic medicinepolicy evaluationpolicy toolsthree-dimensional analysis framework

Identifiers

PMID39035187
PMCPMC11257931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.